Marseille, 13009,
France
Institut Paoli-Calmettes France Technographics
Discover the latest software purchases and digital transformation initiatives being undertaken by Institut Paoli-Calmettes France and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 1700 Institut Paoli-Calmettes France employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Institut Paoli-Calmettes France has purchased the following applications: MBioLIMS for Laboratory Management in 2015 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Institut Paoli-Calmettes France is running and its propensity to invest more and deepen its relationship with Modul-Bio or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Institut Paoli-Calmettes France revenues, which have grown to $240.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Institut Paoli-Calmettes France intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
ERP Services and Operations
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Modul-Bio | Legacy | MBioLIMS | Laboratory Management | ERP Services and Operations | n/a | 2015 | 2015 |
In 2015, Institut Paoli-Calmettes France implemented MBioLIMS to manage tumor bank and cell therapy product workflows at its comprehensive cancer centre in Marseille. The deployment centers on Laboratory Management functions for biobanking, with the application used to establish standardized sample traceability and operational handling across clinical and research sample flows.
The MBioLIMS implementation leverages tumor bank and BRC module usage to provide sample accessioning, inventory and storage management, chain of custody tracking, clinical annotation and cell therapy product tracking. Configuration covers specimen lifecycle management, quality control record capture and metadata management to support both operational staff and quality teams.
Operationally MBioLIMS is integrated into the institution’s IT fabric to improve interoperability with patient identifiers, scheduling data and laboratory workflow information, enabling daily operations for pathology, biobanking and cell therapy units. The integration focus supports data exchanges that maintain sample provenance and facilitate routine coordination between laboratory users and institutional systems.
Governance and process alignment concentrate on operational and quality team workflows, with MBioLIMS serving as the authoritative system for tumor bank traceability and cell therapy sample governance. The implementation improves interoperability with institutional IT and daily operations for operational and quality teams, strengthening end to end sample management and oversight.
|
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||